Replies to post #168773 on Biotech Values

[DewDiligence]

Re: Red flags and newbie mistakes

Your first “bonus” item:

Making your executive team refer to you the CEO as "Doctor" on conference calls…

...is not picayune, but rather is one of the more reliable red flags available to ordinary investors. It applies in spades to Steven Quay, CEO of ATOS and former CEO of NSTK/MRNA; I commented on this many years ago in #msg-3451506.